Why the study?
Is endomyocardial biopsy a safe and useful tool in the diagnosis and monitoring of therapy in patients with Churg-Strauss syndrome cardiac disease?
Population
73-year-old man presenting with signs and symptoms of an acute myocardial infarction, eosinophilia, a…
Design
Case_report
Follow-up
1 month
Key result
Endomyocardial biopsy successfully diagnosed cardiac involvement in a patient with Churg-Strauss syndrome and confirmed the resolution of inflammation after 1 month of high-dose prednisone.
Authors
Loading...
May support endomyocardial biopsy for cardiac EGPA diagnosis and response monitoring; leaves open need for prospective validation.
Case Report (n=1)
Is endomyocardial biopsy a safe and useful tool in the diagnosis and monitoring of therapy in patients with Churg-Strauss syndrome cardiac disease?
Endomyocardial biopsy is a safe and useful tool for diagnosing and monitoring cardiac involvement in Churg-Strauss syndrome.
Carr et al. (1999) conducted a case report in Churg-Strauss syndrome (n=1). Endomyocardial biopsy and high dose prednisone therapy was evaluated on Evidence of inflammation and fibrosis on repeat biopsy. Endomyocardial biopsy successfully diagnosed cardiac involvement in a patient with Churg-Strauss syndrome and confirmed the resolution of inflammation after 1 month of high-dose prednisone.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: